InspireMD (NSPR) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
InspireMD Reports Financial Results for the Third Quarter Ended September 30, 2015
November 10, 2015 7:00 AM ESTBOSTON, MA -- (Marketwired) -- 11/10/15 -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced its financial and operating results for the third quarter ended September 30, 2015.
In its third full quarter of a strategic transition into the carotid and neuro interventional markets utilizing its proprietary MicroNet" technology, key activities included the announced strategic distributor agreement with global interventional therapies company Penumbra, Inc., strengthened intellectual property coverage, including... More

